We provide the first systematic comparison of several EBov real-time RT-PCR a six of which are commercially available using serial dilutions offull-length EBOV RNAs from the 2013-2015 EVD outbreak. In-house assays did not match the performance a the commercial kits even after primer adaptations in ne with recently isolated EBov sequences. This could be explained in part by the lack of extensive reagent optimization